MIM
ETNB

Monashee Investment Management’s 89bio ETNB Stock Holding History

Monashee Investment Management’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-140,000
Closed -$1.56M – 110
2023
Q4 		$1.56M Buy
+140,000
New +$1.29M 0.28% 31
2023
Q2 		– Sell
-75,000
Closed -$1.14M – 78
2023
Q1 		$1.14M Buy
+75,000
New +$978K 0.32% 43
2020
Q4 		– Sell
-40,000
Closed -$1.03M – 294
2020
Q3 		$1.03M Buy
+40,000
New +$1.27M 0.22% 91

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Monashee Investment Management's ETNB Position: Q1 2024 in Review

Monashee Investment Management sold out of 89bio (ETNB) in Q1 2024, closing a stake of 140,000 shares — an estimated $1.56M sold.

Monashee Investment Management first reported a position in ETNB in Q3 2020 and held it in 3 quarters. The position peaked at $1.56M in Q4 2023. 150 funds tracked by Wall St. Rank hold ETNB as of Q1 2024.

  • Monashee Investment Management reported no remaining 89bio position as of Q1 2024 after selling out during the quarter.
  • Monashee Investment Management sold 140,000 89bio shares in Q1 2024, an estimated $1.56M.
  • Monashee Investment Management first reported a position in 89bio in Q3 2020 and held it in 3 quarters.
  • Monashee Investment Management's 89bio position peaked at $1.56M in Q4 2023.
  • 150 funds tracked by Wall St. Rank held 89bio as of Q1 2024.

Based on Monashee Investment Management's 13F filing for Q1 2024, filed 14 May 2024.